Acadia Pharmaceuticals (ACAD) Q1 2025 Earnings

26FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
0.05
0.32
0.59
0.86

Details

Expected EPS
0.215713
Actual EPS
0.86
Surprise EPS
0.64
Surprise Percent
+298.68%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of 0.86 per share for Q1 2025.

0 Comments

Share your thoughts